BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37738883)

  • 1. Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage.
    Cherupalla B; Warren J; Kane A; Trendle M; Tassone P
    Am J Otolaryngol; 2024; 45(1):104051. PubMed ID: 37738883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Going Off Guidelines: An NCDB Analysis of Missed Adjuvant Therapy Among Surgically Treated Oral Cavity Cancer.
    Tassone P; Topf MC; Dooley L; Galloway T; Biedermann G; Trendle M
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1420-1432. PubMed ID: 36939392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
    Chen MM; Chang CM; Dermody S; Rosko AJ; Mierzwa ML; Swiecicki PL; Spector ME; Worden FP; Prince MEP; Chinn SB
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):609-616. PubMed ID: 34365858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.
    Prasad K; Topf MC; Clookey S; Philips R; Curry J; Tassone P
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1200-1207. PubMed ID: 37232479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients.
    Pollom EL; Chin AL; Lee NY; Tsai CJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):758-766. PubMed ID: 28366574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer.
    Howard FM; Kochanny S; Koshy M; Spiotto M; Pearson AT
    JAMA Netw Open; 2020 Nov; 3(11):e2025881. PubMed ID: 33211108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.
    Robinson EM; Lam AS; Solomon I; Brady JS; Pang J; Faraji F; Houlton JJ; Futran ND; Barber BR
    Laryngoscope; 2022 Oct; 132(10):1962-1970. PubMed ID: 35102568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Adjuvant Therapy Based on Detailed Pathologic Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long-Term Outcome Comparison of CGMH and NCCN Guidelines.
    Lin CY; Fan KH; Lee LY; Hsueh C; Yang LY; Ng SH; Wang HM; Hsieh CH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Lee LA; Huang SF; Chang KP; Yen TC; Tay ZY; Wen YW; Lee SR; Liao CT
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):916-925. PubMed ID: 31499138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
    Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
    Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
    Ferris RL; Geiger JL; Trivedi S; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Bauman JE; Ohr JP; Gooding WE; Argiris A
    Ann Oncol; 2016 Dec; 27(12):2257-2262. PubMed ID: 27733374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
    Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
    Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
    Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
    J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of induction chemotherapy for oral cavity squamous cell carcinoma.
    Abdelmeguid AS; Silver NL; Boonsripitayanon M; Glisson BS; Ferrarotto R; Gunn GB; Phan J; Gillenwater AM; Hanna EY
    Cancer; 2021 Sep; 127(17):3107-3112. PubMed ID: 33909292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.